EUIPOProtect this trademark from copycats!
With our trademark monitoring alerts, you are automatically notified by email about copycats and free riders.
The Union trademark ACUITAS THERAPEUTICS was filed as Word mark on 03/06/2023 at the European Union Intellectual Property Office.
It was registered as a trademark on 07/06/2023.
The current status of the mark is "Trademark registered".
| Trademark form | Word mark |
| File reference | 018844140 |
| Application date | March 6, 2023 |
| Publication date | March 29, 2023 |
| Entry date | July 6, 2023 |
| Expiration date | March 6, 2033 |
Trademark owner
6190 Agronomy Road, Suite 405
V6T 1Z3 Vancouver, B.C.
CA
V6T 1Z3 Vancouver, B.C.
CA
Trademark representatives
Leopoldstr. 4
80802 München
DE
goods and services
1
Lipids, lipid nanoparticles, lipid formulations, and nucleic acids, including messenger RNA, for scientific purposes, research purposes, or laboratory use
5
Pharmaceutical preparations, such as, drug delivery agents in the nature of lipid nanoparticle carriers that facilitate delivery of pharmaceutical preparations and nucleic acid therapeutics; pharmaceutical preparations comprised of nucleic acids, including messenger RNA, and lipid nanoparticles; pharmaceutical preparations comprised of lipid nanoparticles; pharmaceutical preparations, such as, vaccines for human use; pharmaceutical preparations for gene silencing, for gene editing, for antibody therapeutics, for protein replacement therapeutics, and for nucleic acid therapeutics
42
Research, development, and evaluation services in the fields of pharmaceuticals, medical therapies, immunology, vaccines, biotechnology, nanotechnology, gene therapy, lipids, lipid formulations, lipid nanoparticles, nucleic acids, including messenger RNA, drug delivery agents, nucleic acid therapeutics, and synthetic chemistry process technology; synthetic chemistry services, such as, design, synthesis, analysis, evaluation, and biophysical characterization of lipids, lipid formulations, and lipid nanoparticles; preclinical study services, such as, conducting pharmacodynamic and pharmacokinetic studies, safety and tolerability studies regarding clinical pathology and histopathology, immune response characterization studies, and bioanalytical services in the fields of pharmaceuticals, medical therapies, immunology, vaccines, biotechnology, nanotechnology, gene therapy, lipids, lipid formulations, lipid nanoparticles, nucleic acids, including messenger RNA, drug delivery agents, and nucleic acid therapeutics; clinical research services, such as, chemical molecular analysis, product optimization, and clinical trial services to pharmaceutical industries; research and development of new formulation products for others; research and development of new pharmaceuticals, medical therapies, vaccines, gene therapies, drug delivery agents, and nucleic acid therapeutics for others; project management services for research and development programs in the fields of pharmaceuticals, medical therapies, immunology, vaccines, biotechnology, nanotechnology, gene therapy, lipids, lipid formulations, lipid nanoparticles, nucleic acids, including messenger RNA, drug delivery agents, nucleic acid therapeutics, and synthetic chemistry process technology; consultancy services in the fields of pharmaceuticals, medical therapies, immunology, vaccines, biotechnology, nanotechnology, gene therapy, lipids, lipid formulations, lipid nanoparticles, nucleic acids, including messenger RNA, drug delivery agents, nucleic acid therapeutics, and synthetic chemistry process technology
45
Regulatory compliance consultancy services in the fields of pharmaceuticals, medical therapies, immunology, vaccines, biotechnology, nanotechnology, gene therapy, lipids, lipid nanoparticles, nucleic acid, including messenger RNA, drug delivery agents, nucleic acid therapeutics, and synthetic chemistry process technology
Trademark history
| Date | Document number | Area | Entry |
|---|---|---|---|
| November 14, 2024 | Transfer / Change of address, Published | ||
| November 14, 2024 | Transfer / Change of address, Published | ||
| October 23, 2024 | Transfer / Change of address, Published |
ID: 11018844140